Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce the appointment of Dr. Danial Schecter as Director of Global Medical Services. Dr. Schecter is widely recognized as an expert in the clinical use of medical cannabis and will use his experience to expand the Company’s network of partner healthcare clinics and support doctors and patients who understand the value of cannabis as medicine.
“I have had the honour of serving a range of patients who, after exhausting traditional pharmaceutical approaches, have reported the remarkable benefits of therapeutic cannabis,” said Dr. Schecter. “As Canopy Growth’s new Director of Global Medical Services, it will be my privilege to share the lessons learned from my vast clinical experience to benefit new cohorts of physicians and patients, both nationally and globally, who are able to access federally regulated medical cannabis.”
Dr. Schecter’s approach will rely on educational and outreach activities, including establishing new mentorship opportunities, developing training modules and organizing advisory boards that will assist healthcare providers in each jurisdiction that allows medical cannabis access. In addition, he will identify and support clinics partnered with Spectrum Cannabis and ensure they operate at the highest standards.
“Dr. Schecter will leverage his extraordinary wealth of front-line clinical experience as we expand the Company’s medical cannabis practice into new jurisdictions,” said Dr. Mark Ware, Chief Medical Officer, Canopy Growth. “We look forward to working with him as we continue our efforts to educate physicians and other healthcare providers who are committed to ensuring patients get the access to medical cannabis they deserve.”
Prior to being appointed to his new role at Canopy Growth, Dr. Schecter was the co-founder and Executive Director of Canabo Medical Clinics, the largest referral-only clinic network specializing in medical cannabis in Canada. He trained thousands of physicians and pharmacists on how to help patients decide if cannabis was the appropriate treatment for their specific medical conditions. Outside of cannabinoid medicine, he holds a fellowship in Hospital Medicine and is an active hospitalist at the Royal Victoria Regional Health Centre in Barrie, Ontario. Dr. Schecter is also a practicing family physician who will continue to provide house calls to at-risk elderly and palliative care patients.
Dr. Schecter’s experience as a patient-focused family physician and leader in the medical cannabis sector makes him a welcome addition to Canopy Growth’s team of healthcare professionals and industry experts. Their combined efforts will further the Company’s mission to provide reliable, consistent medical cannabis products that will improve the lives of patients around the world.
Here’s to Future (medical) Growth.